COSCIENS Biopharma Inc. (CSCI)
$2.72+0.00%Close
BUYRECOVERY · day 2
Key stats
- Market cap
- $9M
- Beta
- 1.85
- P/E (TTM)
- -0.46
- 1W
- +45.45%
- 1M
- +33.99%
- vs SPY 1W
- +44.29%
- vs SPY 1M
- +31.00%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 16
- GROWTH
- 34
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-53.7%
REV YoY-
ROE-89.5%
EPS YoY-
ROA-43.7%
GROSS49
OP-133
NET-111
[VALUATION]
P/E TTM-0.46
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B0.53
P/FCF-
EV/EBITDA0.41
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E17.55
ALTMAN Z-
CURR RATIO3.32
ND/EBITDA-
BETA1.85
Company news
FAQ
- What is LOPJLB’s current signal on CSCI?
- LOPJLB’s latest quantitative signal on COSCIENS Biopharma Inc. (CSCI) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is CSCI in?
- COSCIENS Biopharma Inc. (CSCI) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does COSCIENS Biopharma Inc. (CSCI) do?
- COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend across Canada, Switzerland, Ireland, Denmark, Germany, the United States, and other international territories. The company's flagship product is Macrilen (macimorelin), an orally administered peptido…